Cargando…
Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection–response to Guangting Zeng and Yuchi Zhou
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565760/ https://www.ncbi.nlm.nih.gov/pubmed/37829195 http://dx.doi.org/10.1016/j.lana.2023.100611 |
| _version_ | 1785118765278560256 |
|---|---|
| author | Adegunsoye, Ayodeji Baccile, Rachel Best, Thomas J. Zaksas, Victoria Zhang, Hui Karnik, Rasika Patel, Bhakti K. Solomonides, Anthony E. Parker, William F. Solway, Julian |
| author_facet | Adegunsoye, Ayodeji Baccile, Rachel Best, Thomas J. Zaksas, Victoria Zhang, Hui Karnik, Rasika Patel, Bhakti K. Solomonides, Anthony E. Parker, William F. Solway, Julian |
| author_sort | Adegunsoye, Ayodeji |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10565760 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105657602023-10-12 Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection–response to Guangting Zeng and Yuchi Zhou Adegunsoye, Ayodeji Baccile, Rachel Best, Thomas J. Zaksas, Victoria Zhang, Hui Karnik, Rasika Patel, Bhakti K. Solomonides, Anthony E. Parker, William F. Solway, Julian Lancet Reg Health Am Correspondence Elsevier 2023-10-05 /pmc/articles/PMC10565760/ /pubmed/37829195 http://dx.doi.org/10.1016/j.lana.2023.100611 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Correspondence Adegunsoye, Ayodeji Baccile, Rachel Best, Thomas J. Zaksas, Victoria Zhang, Hui Karnik, Rasika Patel, Bhakti K. Solomonides, Anthony E. Parker, William F. Solway, Julian Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection–response to Guangting Zeng and Yuchi Zhou |
| title | Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection–response to Guangting Zeng and Yuchi Zhou |
| title_full | Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection–response to Guangting Zeng and Yuchi Zhou |
| title_fullStr | Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection–response to Guangting Zeng and Yuchi Zhou |
| title_full_unstemmed | Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection–response to Guangting Zeng and Yuchi Zhou |
| title_short | Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection–response to Guangting Zeng and Yuchi Zhou |
| title_sort | pharmacotherapy and pulmonary fibrosis risk after sars-cov-2 infection–response to guangting zeng and yuchi zhou |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565760/ https://www.ncbi.nlm.nih.gov/pubmed/37829195 http://dx.doi.org/10.1016/j.lana.2023.100611 |
| work_keys_str_mv | AT adegunsoyeayodeji pharmacotherapyandpulmonaryfibrosisriskaftersarscov2infectionresponsetoguangtingzengandyuchizhou AT baccilerachel pharmacotherapyandpulmonaryfibrosisriskaftersarscov2infectionresponsetoguangtingzengandyuchizhou AT bestthomasj pharmacotherapyandpulmonaryfibrosisriskaftersarscov2infectionresponsetoguangtingzengandyuchizhou AT zaksasvictoria pharmacotherapyandpulmonaryfibrosisriskaftersarscov2infectionresponsetoguangtingzengandyuchizhou AT zhanghui pharmacotherapyandpulmonaryfibrosisriskaftersarscov2infectionresponsetoguangtingzengandyuchizhou AT karnikrasika pharmacotherapyandpulmonaryfibrosisriskaftersarscov2infectionresponsetoguangtingzengandyuchizhou AT patelbhaktik pharmacotherapyandpulmonaryfibrosisriskaftersarscov2infectionresponsetoguangtingzengandyuchizhou AT solomonidesanthonye pharmacotherapyandpulmonaryfibrosisriskaftersarscov2infectionresponsetoguangtingzengandyuchizhou AT parkerwilliamf pharmacotherapyandpulmonaryfibrosisriskaftersarscov2infectionresponsetoguangtingzengandyuchizhou AT solwayjulian pharmacotherapyandpulmonaryfibrosisriskaftersarscov2infectionresponsetoguangtingzengandyuchizhou |